You will be logged out in due to inactivity. Please click Ok to extend the session or select Log Out to end the session.
1,606 medical examiner and coroner offices participated in the most recent 2022 NFLIS-MEC Survey, including full surveys and those completing only critical items.
Qualitative Analysis Frequency reported as “routinely” requested from toxicology laboratories by MECs, 2022 NFLIS-MEC survey
During calendar year 2021,
death cases were referred to responding MECs. Of these, 703,049 were accepted by MECs. Overall, 101,582 overdose cases were accepted by responding MECs.
2017 NFLIS-MEC Survey
IN 2021, MECs REPORTED "ROUTINELY" CONDUCTING TOXICOLOGY TESTING FOR THE FOLLOWING DRUGS OR DRUG CLASSES MORE THAN 75% OF THE TIME:
In 2018, DEA expanded the NFLIS program to include two additional continuous drug surveillance components that collect drug-related mortality data from medical examiner and coroner offices (NFLIS-MEC) and drug testing results from toxicology laboratories (NFLIS-Tox) to supplement and complement the current NFLIS-Drug data from drug cases submitted to and analyzed by the Nation's forensic laboratories.
If your office would like to participate in NFLIS-MEC, please review DEA's FAQs document to determine your entity's eligibility to participate in NFLIS and to review other information about each NFLIS component and the next steps for participation. If you have any questions or would like to participate in NFLIS-MEC, please contact the NFLIS team at DEANFLIS@rti.org.
Although DEA does not expect to be able to publish NFLIS-MEC data in the immediate future, DEA has the results from the 2017 NFLIS MEC survey and will soon publish the 2022 NFLIS-MEC Survey report. The next administration of the NFLIS-MEC survey is anticipated to launch in 2027.